Genomic Changes in Colorectal Cancer Linked to Liver Metastases
Author Information
Author(s): Sjoerd C Bruin, Christiaan Klijn, Gerrit-Jan Liefers, Linde M Braaf, Simon A Joosse, Eric H van Beers, Victor J Verwaal, Hans Morreau, Lodewyk F Wessels, Marie-Louise F van Velthuysen, Rob AEM Tollenaar, Laura J van 't Veer
Primary Institution: The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Hypothesis
Can specific genomic aberrations in primary colorectal tumors predict the occurrence of liver metastases?
Conclusion
The study found that liver-specific colorectal cancer metastases can be predicted with high accuracy based on specific genomic changes in the primary tumor.
Supporting Evidence
- KC-SMART analysis identified genomic aberrations on chromosome 20q in tumors of patients who developed liver metastases.
- The LM-PAM classifier distinguished liver metastases with 80% accuracy.
- Chromosome 20q amplification was significantly more common in the liver metastases group compared to others.
- Logistic regression showed a strong association between 20q amplification and liver metastases risk.
Takeaway
Doctors can tell if a colorectal cancer patient might get liver metastases by looking at certain changes in their tumor's DNA.
Methodology
Array Comparative Genomic Hybridization (aCGH) was used to assess DNA copy number changes in primary colorectal tumors from three patient groups.
Potential Biases
Potential selection bias due to the specific patient groups chosen for the study.
Limitations
The study's findings need to be validated in independent cohorts.
Participant Demographics
The study included 356 patients with colorectal cancer, divided into three groups based on their metastasis status.
Statistical Information
P-Value
p<0.00003
Confidence Interval
90% CI: 2.3-141.2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website